|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 | (2006.01) |
| A61K 9/0056 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/009 | (2013.01) | ||
| A61K 9/1623 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/1635 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61P 3/12 | (2006.01) | ||
| A61K 9/2027 | (2013.01) | ||
| A61P 5/18 | (2006.01) | ||
| A61K 9/205 | (2013.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61K 9/2059 | (2013.01) | ||
| A61P 7/08 | (2006.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61P 13/00 | (2006.01) | ||
| A61K 33/26 | (2013.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 13/00 | (2018.01) | ||
| A61P 19/08 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61K 33/26 | (2006.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/12 | (2018.01) | ||
| A61P 5/18 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 7/08 | (2018.01) |
| (11) | Number of the document | 3895700 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21176707.4 |
| Date of filing the European patent application | 2008-11-13 | |
| (97) | Date of publication of the European application | 2021-10-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 07120837 | 2007-11-16 | EP |
| (72) |
WEIBEL-FURER, Ludwig , CH
PHILIPP, Erik , CH
|
| (73) |
Vifor Fresenius Medical Care Renal Pharma, Ltd. ,
Rechenstrasse 37, 9014 St. Gallen,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING IRON OXY-HYDROXIDE |
| PHARMACEUTICAL COMPOSITIONS COMPRISING IRON OXY-HYDROXIDE |